172 related articles for article (PubMed ID: 11834739)
1. Separate functions for the two modules of the membrane-proximal cytokine binding domain of glycoprotein 190, the leukemia inhibitory factor low affinity receptor, in ligand binding and receptor activation.
Voisin MB; Bitard J; Daburon S; Moreau JF; Taupin JL
J Biol Chem; 2002 Apr; 277(16):13682-92. PubMed ID: 11834739
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the immunoglobulin-like domain of gp190, the leukemia inhibitory factor (LIF) receptor, increase or decrease its affinity for LIF.
Bitard J; Daburon S; Duplomb L; Blanchard F; Vuisio P; Jacques Y; Godard A; Heath JK; Moreau JF; Taupin JL
J Biol Chem; 2003 May; 278(18):16253-61. PubMed ID: 12601009
[TBL] [Abstract][Full Text] [Related]
3. Identification of agonistic and antagonistic antibodies against gp190, the leukemia inhibitory factor receptor, reveals distinct roles for its two cytokine-binding domains.
Taupin JL; Legembre P; Bitard J; Daburon S; Pitard V; Blanchard F; Duplomb L; Godard A; Jacques Y; Moreau JF
J Biol Chem; 2001 Dec; 276(51):47975-81. PubMed ID: 11606572
[TBL] [Abstract][Full Text] [Related]
4. Binding of leukemia inhibitory factor (LIF) to mutants of its low affinity receptor, gp190, reveals a LIF binding site outside and interactions between the two cytokine binding domains.
Taupin JL; Miossec V; Pitard V; Blanchard F; Daburon S; Raher S; Jacques Y; Godard A; Moreau JF
J Biol Chem; 1999 May; 274(20):14482-9. PubMed ID: 10318874
[TBL] [Abstract][Full Text] [Related]
5. Leukemia inhibitory factor (LIF) and oncastsin M (OSM) high affinity binding require additional receptor subunits besides GP130 and GP190.
Heymann D; Godard A; Raher S; Bentouimou N; Blanchard F; Cherel M; Hallet MM; Jacques Y
Cytokine; 1996 Mar; 8(3):197-205. PubMed ID: 8833034
[TBL] [Abstract][Full Text] [Related]
6. The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.
Aasland D; Oppmann B; Grötzinger J; Rose-John S; Kallen KJ
J Mol Biol; 2002 Jan; 315(4):637-46. PubMed ID: 11812136
[TBL] [Abstract][Full Text] [Related]
7. The carboxyl-terminal domains of gp130-related cytokine receptors are necessary for suppressing embryonic stem cell differentiation. Involvement of STAT3.
Ernst M; Novak U; Nicholson SE; Layton JE; Dunn AR
J Biol Chem; 1999 Apr; 274(14):9729-37. PubMed ID: 10092661
[TBL] [Abstract][Full Text] [Related]
8. Epitope-function relationships of human leukemia inhibitory factor receptors using a novel set of anti-gp190 mAB.
Blanchard F; Pitard V; Taupin JL; Raher S; Hallet MM; Moreau JF; Godard A; Jacques Y
Int Immunol; 1997 Dec; 9(12):1775-84. PubMed ID: 9466305
[TBL] [Abstract][Full Text] [Related]
9. Involving of the cytoplasmic region of leukemia inhibitory factor receptor alpha subunit, IL-6 related signal transducer-gp130 or fas death domain for MAPK p42/44 activation in HL-60 cell with LIF or anti-Fas IgG.
Liu H; Dan J; Tang S; Wu S
Mol Cell Biochem; 2001 Jan; 217(1-2):113-20. PubMed ID: 11269654
[TBL] [Abstract][Full Text] [Related]
10. Identification of a gp130 cytokine receptor critical site involved in oncostatin M response.
Olivier C; Auguste P; Chabbert M; Lelièvre E; Chevalier S; Gascan H
J Biol Chem; 2000 Feb; 275(8):5648-56. PubMed ID: 10681548
[TBL] [Abstract][Full Text] [Related]
11. Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor.
Plun-Favreau H; Perret D; Diveu C; Froger J; Chevalier S; Lelièvre E; Gascan H; Chabbert M
J Biol Chem; 2003 Jul; 278(29):27169-79. PubMed ID: 12707269
[TBL] [Abstract][Full Text] [Related]
12. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
Terstegen L; Maassen BG; Radtke S; Behrmann I; Schaper F; Heinrich PC; Graeve L; Gatsios P
FEBS Lett; 2000 Jul; 478(1-2):100-4. PubMed ID: 10922477
[TBL] [Abstract][Full Text] [Related]
13. Influence of subunit combinations on signaling by receptors for oncostatin M, leukemia inhibitory factor, and interleukin-6.
Kuropatwinski KK; De Imus C; Gearing D; Baumann H; Mosley B
J Biol Chem; 1997 Jun; 272(24):15135-44. PubMed ID: 9182534
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic domains of the leukemia inhibitory factor receptor required for STAT3 activation, differentiation, and growth arrest of myeloid leukemic cells.
Tomida M; Heike T; Yokota T
Blood; 1999 Mar; 93(6):1934-41. PubMed ID: 10068666
[TBL] [Abstract][Full Text] [Related]
15. Production and characterization of monoclonal antibodies against the leukemia inhibitory factor low affinity receptor, gp190.
Pitard V; Taupin JL; Miossec V; Blanchard F; Cransac M; Jollet I; Vernallis A; Hudson K; Godard A; Jacques Y; Moreau JF
J Immunol Methods; 1997 Jul; 205(2):177-90. PubMed ID: 9294600
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of signaling events mediated by the cytoplasmic domain of leukemia inhibitory factor receptor alpha subunit.
Liu H; Liu S; Tang S; Ji K; Wang F; Hu S
Mol Cell Biochem; 2004 Mar; 258(1-2):15-23. PubMed ID: 15030166
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional studies on the leukemia inhibitory factor receptor (LIF-R): gene and soluble form of LIF-R, and cytoplasmic domain of LIF-R required for differentiation and growth arrest of myeloid leukemic cells.
Tomida M
Leuk Lymphoma; 2000 May; 37(5-6):517-25. PubMed ID: 11042511
[TBL] [Abstract][Full Text] [Related]
18. The mannose 6-phosphate/insulin-like growth factor II receptor is a nanomolar affinity receptor for glycosylated human leukemia inhibitory factor.
Blanchard F; Raher S; Duplomb L; Vusio P; Pitard V; Taupin JL; Moreau JF; Hoflack B; Minvielle S; Jacques Y; Godard A
J Biol Chem; 1998 Aug; 273(33):20886-93. PubMed ID: 9694835
[TBL] [Abstract][Full Text] [Related]
19. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor.
Wang Y; Robledo O; Kinzie E; Blanchard F; Richards C; Miyajima A; Baumann H
J Biol Chem; 2000 Aug; 275(33):25273-85. PubMed ID: 10854424
[TBL] [Abstract][Full Text] [Related]
20. Reconstitution of the functional mouse oncostatin M (OSM) receptor: molecular cloning of the mouse OSM receptor beta subunit.
Tanaka M; Hara T; Copeland NG; Gilbert DJ; Jenkins NA; Miyajima A
Blood; 1999 Feb; 93(3):804-15. PubMed ID: 9920829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]